Modulating Co-Stimulation During Antigen Presentation to Enhance Cancer Immunotherapy

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 12, Iss. 3, 2012-07 ,pp. : 224-235

Bentham Science Publishers

Access to resources Recommend Favorite

A translational bridge to cancer immunotherapy: Exploiting costimulation and target antigens for active and passive T cell immunotherapy

By Vonderheide Robert   June Carl  

Immunologic Research, Vol. 27, Iss. 2-3, 2003-06 ,pp. : 341-355

Humana Press, Inc

Access to resources Recommend Favorite

ICOS Costimulation: Is It the Key to Selective Immunotherapy?

By Sperling A.I.  

Clinical Immunology, Vol. 100, Iss. 3, 2001-09 ,pp. : 261-262

Academic Press

Access to resources Recommend Favorite

Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer

By Hombach Andreas A   Abken Hinrich  

Immunotherapy, Vol. 5, Iss. 7, 2013-07 ,pp. : 677-681

Future Medicine

Access to resources Recommend Favorite

Co-stimulation agonists as a new immunotherapy for autoimmune diseases

By Sun Y.   Subudhi S.K.   Fu Y.-X.  

Trends in Molecular Medicine, Vol. 9, Iss. 11, 2003-11 ,pp. : 483-489

Elsevier

Access to resources Recommend Favorite